PeriCor
Private Company
Funding information not available
Overview
PeriCor is a privately-held, pre-revenue medical device startup focused on innovating in the cardiovascular intervention space. Originating from pediatric clinical needs at Children's National, the company is developing minimally invasive tools and techniques for cardiac electrophysiology procedures to reduce pain, morbidity, and mortality. With a strong academic and clinical founding team, access to rapid prototyping capabilities, and recognition in national competitions, PeriCor is positioned to address a significant unmet need in both pediatric and adult markets. The company appears to be in the pre-clinical or early development stage, advancing its technology platform toward first-in-human studies.
Technology Platform
Integrated platform for developing minimally invasive cardiac intervention tools, leveraging rapid prototyping (3D printing), surgical robotics expertise, and direct clinical input to create novel devices for pacemaker, defibrillator, and ablation procedures.
Opportunities
Risk Factors
Competitive Landscape
PeriCor competes in the cardiovascular device market dominated by giants like Medtronic, Abbott, and Boston Scientific. Its differentiation lies in a pediatric-first, minimally invasive focus and its agile, academic-based development model. It may face competition from other startups also developing novel access tools or robotic-assisted systems for cardiac procedures.